Source:http://linkedlifedata.com/resource/pubmed/id/17889543
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
24
|
pubmed:dateCreated |
2007-10-22
|
pubmed:abstractText |
A set of novel heterocyclic ligands (6-27) structurally related to Oxotremorine 2 was designed, synthesized and tested at muscarinic receptor subtypes (mAChRs). In the binding experiments at cloned human receptors (hm1-5), compounds 7 and 15 evidenced a remarkable affinity and selectivity for the hm2 subtype. The in vitro functional assays, performed on a selected group of derivatives at M(1), M(2), and M(3) tissue preparations, singled out the 3-butynyloxy-5-methylisoxazole trimethylammonium salt 7 as a potent unselective muscarinic agonist [pEC(50): 7.40 (M(1)), 8.18 (M(2)), and 8.14 (M(3))], whereas its 5-phenyl analogue 12 behaved as a muscarinic antagonist, slightly selective for the M(1) subtype [pK(B): 6.88 (M(1)), 5.95 (M(2)), 5.53 (M(3))]. Moreover, the functional data put in evidence that the presence of the piperidine ring may generate a functional selectivity, e.g., an M(1) antagonist/M(2) partial agonist/M(3) full agonist profile (compound 21), at variance with the corresponding quaternary ammonium salt (compound 22) which behaved as a muscarinic agonist at all M(1-3) receptors, with an appreciable selectivity for the cardiac M(2) receptors.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Heterocyclic Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/Muscarinic Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Muscarinic Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Oxotremorine,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Muscarinic,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1464-3391
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
7626-37
|
pubmed:meshHeading |
pubmed-meshheading:17889543-Animals,
pubmed-meshheading:17889543-Cells, Cultured,
pubmed-meshheading:17889543-Drug Evaluation, Preclinical,
pubmed-meshheading:17889543-Guinea Pigs,
pubmed-meshheading:17889543-Heterocyclic Compounds,
pubmed-meshheading:17889543-Humans,
pubmed-meshheading:17889543-Ligands,
pubmed-meshheading:17889543-Molecular Structure,
pubmed-meshheading:17889543-Muscarinic Agonists,
pubmed-meshheading:17889543-Muscarinic Antagonists,
pubmed-meshheading:17889543-Oxotremorine,
pubmed-meshheading:17889543-Rabbits,
pubmed-meshheading:17889543-Receptors, Muscarinic,
pubmed-meshheading:17889543-Recombinant Proteins
|
pubmed:year |
2007
|
pubmed:articleTitle |
Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.
|
pubmed:affiliation |
Istituto di Chimica Farmaceutica e Tossicologica "Pietro Pratesi", Università degli Studi di Milano, Via Mangiagalli 25, Milano 20133, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|